I think this is concerning and needs further scrutiny.
Third member of U.S. FDA advisory panel resigns over Alzheimer's drug approval
A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency's decision to approve Biogen Inc's Alzheimer's disease treatment despite the committee's recommendation against doing so.
Read in Reuters: https://apple.news/AkErD4Jp8SU2cF00_8IoEyQ
Shared from Apple News
Sent from my iPhone
Post a Comment